XML 48 R15.htm IDEA: XBRL DOCUMENT
v3.20.1

Share-Based Payments | 3 Months Ended
--- | ---
Mar. 31, 2020
Share-based Payment Arrangement [Abstract] |
Share-based Payment Arrangement [Text Block] |
| 8. | Share-Based Payments:
The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the three months ended March 31, 2020 and 2019 aggregated $0.08 million and $0.06 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options. The following table sets forth information with respect to nonvested options for the three month period ended March 31, 2020:
|  | Number of Shares |  |  | Weighted Average Grant-Date Fair Value |
Nonvested options – beginning of period |  |  | 514,210 |  |  | $ | 12.36 |
Nonvested options granted |  |  | 9,000 |  |  | $ | 12.16 |
Nonvested options vested or forfeited |  |  | (10,180 | ) |  | $ | 10.10 |
Nonvested options – end of period |  |  | 513,030 |  |  | $ | 12.40 |
Share-based payment expense decreased income before income taxes by $0.12 million and $0.96 million for the three months ended March 31, 2020 and 2019, respectively, and decreased net income attributable to Inter Parfums, Inc. by $0.18 million and $0.58 million for the three months ended March 31, 2020 and 2019. The following table summarizes stock option information as of March 31, 2020:
|  | Shares |  |  | Weighted Average Exercise Price |
Outstanding at January 1, 2020 |  |  | 815,800 |  |  | $ | 49.89 |
Options granted |  |  | 9,000 |  |  |  | 69.11 |
Options forfeited |  |  | (2,140 | ) |  |  | 57.03 |
Options exercised |  |  | (18,940 | ) |  |  | 33.82 |
Outstanding at March 31, 2020 |  |  | 803,720 |  |  |  | $ 50. 46 |
Options exercisable |  |  | 290,690 |  |  | $ | 35.09 |
Options available for future grants |  |  | 566,835 |  |  |  |  |
As of March 31, 2020, the weighted average remaining contractual life of options outstanding is 3.78 years (2.38 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $5.3 million and $3.9 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $5.6 million. Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2020 and March 31, 2019 were as follows:
(In thousands) |  | March 31, 2020 |  |  | March 31, 2019 |
Cash proceeds from stock options exercised |  | $ | 641 |  |  | $ | 2,251 |
Tax benefits |  |  | — |  |  |  | 300 |
Intrinsic value of stock options exercised |  |  | 733 |  |  |  | 2,226 |
The weighted average fair values of the options granted by Inter Parfums, Inc. during the three months ended March 31, 2020 and 2019 were $12.16 and $14.83 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value of options granted. The assumptions used in the Black-Scholes pricing model for the periods ended March 31, 2020 and 2019 are set forth in the following table:
|  | March 31, 2020 |  |  | March 31, 2019 |
Weighted average expected stock-price volatility |  |  | 25 | % |  |  | 27 | %
Weighted average expected option life |  |  | 5 years |  |  |  | 5 years |
Weighted average risk-free interest rate |  |  | 1.4 | % |  |  | 2.5 | %
Weighted average dividend yield |  |  | 2.5 | % |  |  | 2.0 | %
Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continue to increase. In December 2018, Interparfums SA, our 73% owned French subsidiary, approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2022. In order to avoid dilution of the Company’s ownership of Interparfums SA, all shares to be distributed pursuant to the plan will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA in prior years. In March 2020, due to the potential impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed, after forfeited shares, was reduced from 142,571 to 82,162. As the Company had already purchased shares in contemplation of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to treasury shares at Interparfums SA level. Employee turnover was also taken into account in the calculation. The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The original cost of the grant was approximately $4.4 million, and the March 2020 revaluation resulted in a reduction of the cost, to approximately $2.5 million. As a result, a $0.3 million reduction of cost, net, was recorded for the three months ended March 31, 2020.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration